- $3.18bn
- $2.80bn
- $2.86bn
- 91
- 62
- 93
- 96
C2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,974 | 1,977 | 1,820 | 2,643 | 2,864 |
Cost of Revenue | |||||
Gross Profit | 1,851 | 1,847 | 1,738 | 2,512 | 2,597 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,833 | 1,801 | 1,664 | 2,173 | 2,547 |
Operating Profit | 141 | 176 | 156 | 470 | 316 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 134 | 151 | 164 | 433 | 296 |
Provision for Income Taxes | |||||
Net Income After Taxes | 105 | 107 | 116 | 331 | 213 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 103 | 105 | 114 | 326 | 210 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 102 | 104 | 112 | 319 | 205 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.39 | 2.86 | 2.51 | 6.22 | 4.89 |
Dividends per Share |